Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / why moonlake immunotherapeutics stock shot up 41 1 o


MLTX - Why MoonLake Immunotherapeutics Stock Shot Up 41.1% on Tuesday

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company that specializes in therapies for inflammatory skin and joint diseases, saw its shares jump 41.1% on Tuesday.

The stock closed at $6.38 on Friday, then opened at $7.55 on Tuesday after the Memorial Day weekend, before rising to a high of $9 just after the opening bell. The stock has a 52-week high of $15.19 and a low of $4.25, and is down more than 25% this year.

Image source: Getty Images.

Continue reading

For further details see:

Why MoonLake Immunotherapeutics Stock Shot Up 41.1% on Tuesday
Stock Information

Company Name: MoonLake Immunotherapeutics
Stock Symbol: MLTX
Market: NASDAQ

Menu

MLTX MLTX Quote MLTX Short MLTX News MLTX Articles MLTX Message Board
Get MLTX Alerts

News, Short Squeeze, Breakout and More Instantly...